[HTML][HTML] Remdesivir for the treatment of COVID‐19

F Grundeis, K Ansems, K Dahms… - … of systematic reviews, 2023 - ncbi.nlm.nih.gov
Background Remdesivir is an antiviral medicine approved for the treatment of mild‐to‐
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …

Novel semi-parametric tobit additive regression models

H Huang - arxiv preprint arxiv:2107.01497, 2021 - arxiv.org
Regression method has been widely used to explore relationship between dependent and
independent variables. In practice, data issues such as censoring and missing data often …

Joint Modeling of Longitudinal and Survival Data with Censored Single-index Varying Coefficient Models

J Shangguan - arxiv preprint arxiv:2107.04496, 2021 - arxiv.org
In medical and biological research, longitudinal data and survival data types are commonly
seen. Traditional statistical models mostly consider to deal with either of the data types, such …